Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology

Gynecologic Cancer Clinical Trial

— LETSGO  

Official title:

Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology: Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03453788
• Other study ID #: LETSGOpilot
• Status: Completed
• Phase: N/A
• Start date: March 20, 2018
• Est. completion date: May 31, 2019

Study information

• Verified date: September 2019
• Source: Sorlandet Hospital HF
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This pilot study is evaluating a new smartphone application named the LETSGO app. The LETSGO app is designed to promote empowerment in patients after treatment for gynecological cancer.

Description:

Gynecological cancer treatment is increasingly successful, resulting in a rising number of cancer survivors. Many gynecological cancer survivors may experience late side effects from their cancer treatment. In addition, evidence is accumulating that an active lifestyle may increase empowerment and may positively influence well-being after cancer treatment. Through the LETSGO smartphone app, women treated for gynecological cancer will get access to individualized posttreatment information on side effects as well as tailored physical activity advices in order to assume more responsibility for achieving the best outcomes from her care. The participants will also regularly answer patient reported outcomes regarding possible recurrence though the app. As a first step the smart-phone application will be pilot-tested.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: May 31, 2019
• Est. primary completion date: May 31, 2019
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients diagnosed and treated for gynecological cancer who will be followed up at the gynecological outpatient clinic in Kristiansand or Arendal

• No cognitive barriers.

Exclusion Criteria:

• < 18 years

• Not able to read Norwegian

Related Conditions & MeSH terms

• Gynecologic Cancer

Intervention

Device:
• LETSGO app
LETSGO pilot test Group will test LETSGO app and partially nurseled follow-up

Locations

Country	Name	City	State
Norway	Sorlandet Hospital	Kristiansand	Vest Agder

Sponsors (3)

Lead Sponsor	Collaborator
Sorlandet Hospital HF	University of Agder, Uppsala University

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Satisfaction with LETSGOapp	Evaluate satisfaction with app through patient interviews	8 months
Secondary	Recruitment rate	Evaluate the patient recruitment rate	6 months
Secondary	Acceptability of goal setting	Evaluate acceptability of goalsetting through changes in Activity level	8 months